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mjedrzejas@chori.orgStreptococcus pneumoniae hyaluronan lyase is a surface enzyme of this
Gram-positive bacterium. The enzyme degrades several biologically
important, information-rich linear polymeric glycans: hyaluronan, unsul-
fated chondroitin, and some chondroitin sulfates. This degradation
facilitates spreading of bacteria throughout the host tissues and
presumably provides energy and a carbon source for pneumococcal cells.
Its b-elimination catalytic mechanism is an acid/base process termed
proton acceptance and donation leading to cleavage of b-1,4 linkages of the
substrates. The degradation of hyaluronan occurs in two stages, initial
endolytic cuts are followed by processive exolytic cleavage of one
disaccharide at a time. In contrast, the degradation of chondroitins is
purely endolytic.
Structural studies together with flexibility analyses of two streptococcal
enzymes, from S. pneumoniae and Streptococcus agalactiae, allowed for
insights into this enzyme’s molecular mechanism. Here, two new X-ray
crystal structures of the pneumococcal enzyme in novel conformations are
reported. These new conformations, complemented by molecular
dynamics simulation results, directly confirm the predicted domain
motions presumed to facilitate the processive degradative process. One
of these new structures resembles the S. agalactiae enzyme conformation,
and provides evidence of a uniform mechanistic/dynamic behavior of this
protein across different bacteria.
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ing author:has also been found in species such as Enterococcus,
Staphylococcus, Streptomyces, and Propionibacterium.
In Streptococcus pneumoniae Hyal is present on the
majority of strains of this organism examined to
date and its expression is directly related to
virulence of this organism.1,2 The enzyme degrades
essential components of the host’s extracellular
matrix (ECM), hyaluronan (HA), unsulfated chon-
droitin (CH), and certain chondroitin sulfates
(CHS), and as such it facilitates bacterial spread
among the host tissues. By doing so, it also provides
an abundant source of carbon and energy for
bacterial cells. The enzyme is found in two forms,
the first closely associated with bacterial cells, the
second a cell-free form presumably released from
bacterial cells by the action of sortase enzymes.2–4d.
Figure 1.Modular structure of bacterial Hyals. Bacterial
Hyals are composed of four domains, a substrate-binding
module, a spacer domain, a major catalytic domain
(a-domain), followed by a C-terminal domain (b-domain)
that regulates HA access to the cleft.6 The N-terminal
substrate-binding module and the C-terminal domain are
connected to the rest of the protein by peptide linkers.
1166 Flexibility of Hyaluronan LyaseThe cell-attached Hyal is anchored to the surface of
bacterial cell wall through a covalent linkage to the
cross-bridges of the wall’s peptidoglycan.5,6 As is
the case for many glycan active enzymes, Hyal
molecules contain various distinct domains, each
with a well-defined and specific function related to
the enzymatic role of this protein. Hyal is a four-
domain protein consisting of a presumed
N-terminal HA/CH/CHS-binding domain,
followed by a spacer domain, the catalytic domain
(termed a-domain), and the C-terminal domain
(termed b-domain) that modulates the access of the
substrate to the catalytic machinery (Figure 1).6–8
The full-length four-domain pneumococcal mole-
cule in its recombinant form from Escherichia coli is
unstable and undergoes degradation by a (auto)-
proteolytic process.9,10 The largest stable enzyme is
composed of the two C-terminal domains, a and
b-domain, and retains essentially full catalytic
activity in vitro.2,9 The structure of these two major
domains has been elucidated by X-ray crystallo-
graphy8 and was followed by a variety of
structural,11–13 biochemical and molecular biology
studies.8,12,14 These studies have led to the formu-
lation of the proposed mechanism of catalysis for
this enzyme8 and its mode of action during
degradation of different substrates.12–14 The full-
length enzyme contains additional residues at the N
terminus arranged in two domains6 that are not
catalytically important (Figure 1). The first of these
domains is clearly a substrate (HA/CH/CHS)
binding domain that is thought to act as to enhance
the Hyal affinity for substrates.6,15 The second,
small domain acts as a spacer to distance theTable 1. Crystal structures referred to in this work and their
Short name Bacterium Ligand






SpnHyal-vitamin C Vitamin C
SagHyal S. agalactiae None
SagHyal-holo Hyaluronan hexasacch
a The apo structure used for the MD studies is identical with the hol
computationally removed. The native structure of the S. pneumoniaecatalytic domain from the substrate-binding
domain at the extreme N terminus and thus to
facilitate processive mechanism of feeding the
substrate for catalysis.6 In addition, flexibility
studies revealed several significant domain motions
and allowed for their putative associations with
specific roles necessary for catalysis and proces-
sivity.13 One of these principal modes of domain
motion was found to correspond to a structural
difference evident from a comparison of the first
pneumococcal Hyal structure (SpnHyal) with that
of the Streptococcus agalactiae enzyme.7,16 (SagHyal;
see Table 1 for nomenclature of the main crystal
structures discussed here). However, at that stage
the possibility could not be excluded that
such structural differences were due to sequence
differences between the two bacterial Hyals.
The main feature of the catalytic a-domain is the
presence of a large, long cleft where the substrates
bind and undergo catalysis. This domain exhibits
high flexibility that presumably facilitates the
mechanism of action of substrate degradation.
A flexibility analysis identified three distinct
domain motions involving:13,17 (i) a rotation/
twisting motion of the sides of the cleft that yields
a w10 A˚ movement along the cleft axis; (ii) an
opening/closing of the substrate-binding cleft
accompanied by movement of catalytic amino
acid residues and those responsible for the release
of the product of degradation. The third movement
(iii) involves a shift in position of the b-domain
resulting in an effective opening and closing of the
access/entrance to the cleft. This motion depicts
the functional role of the b-domain as the
modulator of access to the enzyme’s cleft. In a
putative model, these motions are directly related
to the enzyme’s function: catalysis, endolytic
“random-bite” degradation, and exolytic cleavage
of one disaccharide at a time from the reducing to
non-reducing direction in a processive manner as
has been described.18 Of the simulated domain
motions, the opening/closing mode of the cleft (ii)
was found to agree closely with the observed
differences between the crystal structures of
SagHyal and SpnHyal.17
In the current work we report the structures of
S. pneumoniae Hyal in two new conformations
that directly reflect the flexibility and motion
of the enzyme. These structures confirm theshort names






2.80 2brw This work
3.30 2brv This work
2.00 1f9g 21
2.10 1f1s 7
aride 2.20 1lxm 17
o structure of the complex (PDB code 1loh) but with HA substrate
enzyme was also reported (PDB code 1egu).8
Flexibility of Hyaluronan Lyase 1167previously predicted flexibility properties of this
enzyme as well as its functional and mechanistic
properties. The new structures also reveal that the
structural differences previously observed for
different bacterial Hyals are not primarily due to
sequence differences. Rather, these structures,
together with additional molecular dynamics simu-
lation results, reflect a set of specific domain
motions likely to be common to all bacterial Hyal
enzymes.Figure 2. Three-dimensional structures of (a) Hyal fro
hexasaccharide substrate, and (b) the catalytic portion of the p
residues that are important for catalysis. The domains, the c
atoms are color-coded by atom type: green, carbon; red, oxyg
protein residue bonds are in green. The hydrophobic patch po
by thick black lines. HA1 and HA2 are HA disaccharides. The
the reaction. The thin lines represent hydrogen bonds or, in t
thought to abstract during the reaction.ResultsDescription of the new pneumococcal Hyal
structures
The individual domain structures of Hyal in the
two new conformations, SpnHyal-PEGMME and
SpnHyal-MALONATE, are similar to those
observed in earlier crystal structures8,11,13 (Figure 2;m S. pneumoniae in perpendicular views with bound
neumococcal enzyme cleft with the bound substrate and
atalytic cleft, residues, and the substrate are labeled. The
en; blue, nitrogen. HA substrate bonds are in yellow and
sitioning interactions with the HA substrate are depicted
glycosidic bond between HA1 and HA2 is cleaved during
he case of H399, its relationship to C5 whose proton it is






Space group P21 C2
Unit cell dimensions
a (A˚) 83.4 117.7
b (A˚) 83.3 101.1
c (A˚) 98.7 85.2







Completenessa 88.4 (78.2) 93.8 (84.0)
I/s(I)a 7.6 (2.2) 6.3 (2.3)
Multiplicity1a (%) 2.8 (2.6) 4.4 (5.0)
Rmerge




Sulfate atoms 10 0




Number of reflections1 29,209 (4413) 11,046 (1526)
R (%)a 23.1 (31.7) 30.2 (51.3)
Rfree (%)
a 27.7 (38.4) 32.7 (52.3)
Mean temperature factor B (A˚2)
All atoms 33.1 55.1
Protein 33.2 54.4
Protein main-chain 31.4 54.1
Protein side-chain 34.9 54.6
Sulfate or malonate 67.2 108.8
Solvent 20.7 –
rms deviation from ideal values
Bond lengths (A˚) 0.008 0.007
Bond angles (deg.) 1.59 1.08
a Values in parentheses are for the highest resolution shell
(SpnHyal-PEGMME, 2.95–2.80 A˚; SpnHyal-MALONATE, 3.48–3.
30 A˚).
1168 Flexibility of Hyaluronan LyaseTable 2). The nomenclature PEGMME and MAL-
ONATE indicates the main crystallization agent
used to obtain diffracting crystals of this molecule in
two new conformations. The crystallized Hyal
molecule is composed of two domains, the catalytic
domain (a-domain) having an a5/a5 barrel struc-
ture and the b-domain comprised mainly of an
antiparallel, three-layer b-sandwich) (Figure 2). As
before, the catalytic cleft transverses the a-domain.
The active site of the enzyme is located within the
barrel domain on one side of the cleft area.13,19–21
Both new structural conformations of the pneumo-
coccal Hyal enzyme have structural differences
from previously observed Hyal crystal structures.
These were analyzed using intra-domain root-
mean-square deviation (rmsd) calculations and
Dyndom to describe domain motions. These
differences are of quite different nature in the two
new structures.
In SpnHyal-PEGMME there are two molecules in
the asymmetric unit. Specific local conformational
differences were observed and accounted for
during refinement, but the two chains are never-
theless very similar; 721 Ca atoms may be fit with an
rmsd of just 0.3 A˚. For the purposes of other
analyses, one chain (chain A) only was used.The b-domain (residues 539–890) superimposes
well on the corresponding domain of the original
Hyal structure (SpnHyal; see Table 1), 352 Ca atoms
superimpose with an rmsd of 0.26 A˚. The a-domain
(residues 170–537) fits much less well yielding an
rmsd of 1.82 A˚ for 367 Ca atoms. This difference is
due to the opening of the substrate-binding cleft in
the SpnHyal-PEGMME structure and was analyzed
further using Dyndom22 to study dynamic rather
than structural domains. Dyndom defines two
dynamic domains, the first containing just residues
from the a-domain, 173–378 and 420–431, the
second composed of the entire b-domain as well
as portions of the a-domain, residues 379–419 and
432–888. In the SpnHyal-PEGMME structure these
dynamic domains are differently positioned with
respect to each other so that the substrate binding
cleft is significantly wider than in all earlier
pneumococcal Hyal structures, including the
complexes with substrates and/or products. The
extent of rotation of the two domains around hinge
regions is measured as 15.58 by Dyndom. At the
catalytic site, the Ca–Ca distance between two
catalytic residues Asn349 and Tyr408 (Figure 2(b))
isw7.7 A˚ in the original Hyal structures but is 9.7 A˚
in the SpnHyal-PEGMME structure. Further from
the catalytic center, the cleft opening is much more
dramatic, the Ca–Ca distance between Asn290, a
neighbor of hydrophobic patch residues
(Figure 2(b)), and its nearest neighbor across the
cleft Asn480 (not shown), is 8.4 A˚ in SpnHyal, but
14.9 A˚ in SpnHyal-PEGMME. This widening of the
cleft is reminiscent of that observed earlier in the
SagHyal structure.7 Indeed the dynamic domains
defined for the SpnHyal versus SagHyal comparison
are very similar to those described for the compari-
son of SpnHyal with SpnHyal-PEGMME. However,
the SpnHyal-PEGMME cleft opening differs from
that observed in the S. agalactiae enzyme in two
important respects. First, it is still wider, 15.58
compared to 13.18. The second difference between
the SpnHyal-PEGMME and SagHyal structures is
that the cleft opening of the former is accompanied
by another smaller difference, the rotation of the
side of the cleft close to the b-domain in the HA
reducing direction (Figures 2(b) and 3(a)). Such a
rotation was not observed when comparing the
original SpnHyal and SagHyal structures. It, too, is
evidence in support of enzyme flexibility that
facilitates catalysis (see below).
In the SpnHyal-MALONATE structure the
structural differences are subtler than in that
of SpnHyal-PEGMME. The whole SpnHyal-
MALONATE structure may be superimposed on
the SpnHyal structure with an rmsd of 0.6 A˚ for 719
Ca residues. Structural differences are greater in the
a-domain (rms of 0.7 A˚ for 367 superimposed Ca
atoms) than in the b-domain (rms of 0.5 A˚ for 352
superimposed Ca atoms). The average cleft width is
more in line with that of SpnHyal, but is somewhat
wider. Using the same benchmark as above, the
inter-Ca distance between Asn290 and Asn480 is
9.6 A˚ (compared to w8.4 A˚ in earlier structures).
Figure 3 (legend next page)
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Figure 3. Structural alignment and comparison of the S. pneumoniae Hyal-PEGMME and Hyal-MALONATE structures
of the enzyme in new conformations with structures of S. pneumoniae Hyal (holo) and S. agalactiae enzyme. The structures
were aligned with SpnHyal using the most similar portions of the a-domain for the structures involved (color-coding for
structures: SpnHyal-holo (red) with bound HA hexasaccharide substrate (ball and sticks, red), SpnHyal-PEGMME
(yellow), SpnHyal-MALONATE (green). The orientations of structures in (a)–(d) are similar to the orientation of the
active residues in Figure 2(b). (a) Stereo view of SpnHyal-PEGMME aligned with SpnHyal-holo. (b) Stereo view of
SpnHyal-MALONATE aligned with SpnHyal-holo. (c) Stereo view of SpnHyal-holo aligned with SagHyal. The S. agalactiae
enzyme has the b-sheet spacer domain at its N-terminal end and a wider HA-binding cleft. (d) Side-by-side view of
potential distribution inside the catalytic cleft for representative structures. The location of catalytic, hydrophobic,
negative, and positive patches as well as the reducing/non-reducing ends of the HA substrate are labeled. The
electrostatic potential magnitude is held constant for all enzyme panels, and is color-coded as follows: blue, positive; red,
negative.
1170 Flexibility of Hyaluronan LyaseAlso a small rotation of the cleft side that is in the
proximity of the b-domain is evident. For this
structure, however, the rotation is towards the non-
reducing direction of the bound HA substrate in the
opposite direction than that of the SpnHyal-
PEGMME conformation (Figures 2(b) and 3(b)).
There are relatively large differences in and around
the active site particularly in the vicinity of a bound
malonate ion (from the crystallization solution). The
differences related to the bound malonate ion are
presumed to be non-physiological and may have
been induced by crystallization conditions. They do
not contribute to the rotation described above.
For further analysis, the new structures were
superimposed (using the a-domain) on the
SpnHyal-holo enzyme structure, presumably the
conformation most closely resembling the catalyti-
cally competent state. The relative positions of
specific regions within the catalytic site, the
hydrophobic patch, the positive patch and the
negative patch8 (Figure 2(b)), were analyzed. It
appears that the only part of the enzyme that does
not vary significantly is the hydrophobic patch. The
positions of Trp291, Trp292, and Phe343 (and
equivalents for SagHyal) in all structures of
bacterial Hyals superimpose to within 1 A˚. In
sharp contrast, in the SpnHyal-PEGMME structure
relative to the SpnHyal-holo enzyme structure,
Tyr408 and His399, are shifted by w4.4 A˚ along
the increased width of the cleft, whereas Asn349 is
translocated by w4.5 A˚ in the reducing enddirection of the substrate and along the cleft axis
(Figure 2(b)). The same distances for the SpnHyal-
MALONATE structure comparison are around
w1.0 A˚, showing its resemblance to the SpnHyal-
holo structure in this respect. Interestingly, for
SagHyal distances of w4.4 A˚ for Tyr408 and
His399 are measured corresponding to a cleft
opening, but Asn349 positions are similar to within
1 A˚. Finally, the residues of negative patch Glu388,
Asp398, and Thr400 appear to move the most.
Compared to SpnHyal-holo, in the SpnHyal-
PEGMME structure this patch is essentially trans-
located as a whole by w4.8 A˚ in the reducing HA
direction along the cleft. The other two structures
show opposite translocation towards the non-
reducing HA end by w1.8 A˚ for SpnHyal-
MALONATE and w3.5 A˚ for SagHyal.
Analysis of shape and distribution of electrostatic
potential within the cleft highlights marked differ-
ences. The electrostatic potential does not vary
significantly during enzyme flexing leaving
unchanged the positions of the positive patch (at
the non-reducing end) and the negative patch sited
at the reducing end (Figure 3(d)).13,17 Presumably
their respective functions of continuous substrate
binding (positive patch) and the release of the
disaccharide product (negative patch) remain
important throughout the catalytic cycle. In con-
trast, the shape of the cleft varies significantly
among all structures. In the closed conformation of
SpnHyal-holo it is even covered by a bridge over
Flexibility of Hyaluronan Lyase 1171the catalytic residues forcing the substrate to thread
through the cleft for catalysis. In SpnHyal-
PEGMME the cleft is widely open, in a confor-
mation that would facilitate processivity by
allowing easy substrate translocation towards the
reducing end.8,18 The remaining structures appear
to illustrate intermediate cleft opening/closing
stages, in the SpnHyal-MALONATE structure the
cleft is nearly closed and in the SagHyal structure it
is nearly open.
Bacterial Hyals are flexible
The Hyal enzyme exhibits a high flexibility that
facilitates the mechanism of action of this enzyme.
A previous flexibility analysis revealed three major
types of motion of the enzyme (Figure 4):13,17 (i) a
rotation/twisting motion of the whole a-domain
relative to the top half of the b-domain (Figure 4(a));
(ii) an opening/closing domain motion influencing
the width of substrate-binding cleft (Figure 4(b));
and (iii) the mobility of loops from the b-domain,
relative to the a-domain, that are involved in the
formation of the side of the cleft resulting in
opening/closing of the access/entrance to the cleft
(Figure 4(c)). For the sake of clarity we maintain the
same numbering of motions in the present work.
Here, we present multi-nanosecond molecular
dynamics simulations of SpnHyal-holo and
SpnHyal-apo in explicit solvent. These represent a
significant advance on the earlier computational
analyses made with the computationally efficient
but quantitatively less rigorous CONCOORD pro-
gram.17,23 These simulations confirm the results
from the previous flexibility analysis and reveal
these three types of domain motion as the principal
modes of collective fluctuation as derived from a
principal components analysis (PCA). In both
molecular dynamics (MD) simulations the open-
ing/closing mode of the cleft (ii) is the largest-
amplitude fluctuation. As can be seen in Figure 5,
the extent of the opening is in line with the X-ray
structures, with the most open structures being
even more widely opened than the SagHyal and
SpnHyal-PEGMME crystal structures. The opening
motion is found to be reversible in the simulations,
with the most closed conformations demonstrating
the same degree of closure as the X-ray structures of
the closed enzyme, SpnHyal. Along this opening
mode, the SagHyal structure, and others from the
same species (green), exhibit a slightly higher
degree of opening than the SpnHyal-PEGMME
structure.
An rmsd analysis was carried out to quantify the
structural differences. The rmsd between the
crystallographic starting structure of the simu-
lations (PDB code 1loh (Table 1), the “closed”
conformation) and the SpnHyal-PEGMME struc-
ture (the “open” conformation) is 2.2 A˚. During the
simulation of SpnHyal-apo the rmsd, compared to
the PEGMME structure, decreases to as little as
1.2 A˚. Similarly for the simulation of SpnHyal-holo it
is reduced to as little as 1.2 A˚. This confirms that inboth simulations the opening mode is significantly
sampled. Interestingly, the MD simulation inclu-
ding a hyaluronan hexasaccharide does not sample
the more open configurations to the same extent as
the simulation of SpnHyal-apo within the same time
span of 50 ns (Figure 5(a)), suggesting that the
substrate locks the protein in a more closed
conformation. The maximal amplitude of the open-
ing of the cleft of SpnHyal-apo is observed to be up
to 12.8 A˚ (measured as the difference between the
Ca–Ca separations of Asn231 and Gly769 in the
most open and least open trajectory snapshots) In
the simulation of SpnHyal-holo the extent of the
opening of the cleft, measured in the same way, is
observed only up to 6.5 A˚ (see Figure 5(a) and
Table 3). This is further quantified by the mean
projection along this mode for the SpnHyal-apo
simulation of 0.64G1.16 (standard deviation) while
for the SpnHyal-holo simulation it is 0.01G0.51. For
comparison, the Asn231-Gly769 distances of the
SpnHyal-holo, SpnHyal-PEGMME and SagHyal
structures are 14.0 A˚, 22.1 A˚ and 21.6 A˚.
The second-largest amplitude domain motion
observed in the simulations corresponds to the
twisting mode (i) from the original flexibility
analysis. This mode results in a reciprocal motion
of the two domains with respect to the cleft, and
might therefore enable an effective translocation of
the substrate along the cleft. This presumption is
supported by the extent of the twisting motion in
the simulations. In the simulation of SpnHyal-apo
the a-domain is observed to be shifted with respect
to the b-domain due to this twisting mode by up to
10.92 A˚. This extent was measured as the separation
between the Ca atoms of Asp340 for the super-
imposed most twisted and least twisted snapshots
from the trajectory. Strikingly, this is also approxi-
mately the length of a disaccharide unit of the
hyaluronan substrate. Also along this mode, the
simulated motions agree closely with the crystallo-
graphic structural differences.
Along this twisting mode (i), the SpnHyal-
PEGMME structure represents a structural differ-
ence in the opposite direction as the S. agalactiae
X-ray structures, SagHyal. The MD simulations
span the complete range sampled by the X-ray
structures, suggesting that this mode also reflects an
intrinsic mode of flexibility of the protein. These
results also indicate that, although both the open-
ing/closing (ii) and the twisting mode (i) are
accessible to S. pneumoniae Hyal, these two modes
appear to be coupled during the simulation, leaving
the S. agalactiae X-ray structures (green) unsampled
during the simulations. Thus, although the S. pneu-
moniae and the S. agalactiae X-ray structures are both
reflecting the inherent flexibility of this family of
enzymes, part of the structural difference presum-
ably results from the apparent sequence differences.
Mode (iii), corresponding to a bending of the two
domains that influences the width of the cleft
entrance/exit, is also the third-largest amplitude
mode from the MD simulations. Along this mode,
the SpnHyal structure samples an intermediate
Figure 4. The three principal
modes of collective fluctuation for
bacterial Hyals. The motions
described are marked by arrows.
The yellow arrow corresponds to
a rotation axis for the domain
motion described and the white
arrows are purely descriptive.
The different colors highlight
independently flexible portions
of the enzyme (red and blue
domains and their green linker;
these are different than the struc-
tural a and b- domains and their
linker. Motion (i) describes a
twisting motion of the two
domains, putatively enabling sub-
strate translocation across the
cleft; (ii) corresponds to a closure
mode, opening and closing the
substrate cleft; (iii) describes a
bending mode putatively facilitat-
ing substrate access and product
release at the gorge entry and
exit, respectively.
1172 Flexibility of Hyaluronan Lyaseposition and the SpnHyal-PEGMME structure and
SagHyal structures represent a conformation with
the entrance opened and the exit closed. The MD
simulations demonstrate that this motion issampled to the same extent in the opposite
direction, thereby enabling opening the exit and
closing the entrance to the cleft. The amplitude of
this motion was measured as the difference between
Figure 5. MD trajectories (blue and magenta traces) together with X-ray structures (circles) of Hyal projected onto the
two principal modes of structural divergence among all bacterial Hyal structures. (a) The graph demonstrates
the opening/closing motion of the cleft (motion (ii)) revealed by the principal mode of structural divergence (x-axis). The
50 ns trajectory of the SpnHyal-apo simulation (blue) samples this motion in close agreement with the structural data
available, whereas the hexasaccharide-bound SpnHyal-holo remains in a more closed configuration (magenta). Also
along the twisting mode (i), the simulations sample a similar range as the X-ray structures, leaving only the S. agalactiae
X-ray conformations unsampled. The arrows point to two structure snapshots from the simulations, depicting the most
open (left) and closed (right) sampled configurations from the simulation. (b) Similar projection of MD trajectories
reveals the twisting motion (motion (i); x-axis) and the opening/closing motion of the entrance of the cleft (motion (iii); y-
axis). The SpnHyal-apo and SpnHyal-holo simulations (blue and magenta traces, respectively) sample this motion, again
in close agreement with the structural data.
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Table 3. The extent of the dynamic domain motions in








and closing of the cleft)
12.8 6.5




and closing of the access
to the cleft)
9.1 5.5
See the text for the details of the measurements.
1174 Flexibility of Hyaluronan Lyasethe Ca–Ca separations of Asn341 and Asn580 in the
trajectory snapshots with most open and least open
cleft entrances in the same way as for the mode (ii).
This distance was found to be maximally 9.08 A˚ in
the simulation of SpnHyal-apo, whereas for
SpnHyal-holo the amplitude of this cleft-access
mode was found to be maximally 5.47 A˚. Thus,
this motion is significantly better explored in the
SpnHyal-apo structure.Discussion
We present here novel structures of SpnHyal.
They were obtained using different crystallization
conditions than those hitherto employed. As such, it
could be argued that they do not necessarily reflect
physiologically relevant conformations. However,
several factors lead us to believe in the validity and
relevance of the structures. First, although precipi-
tant can certainly influence the crystallized confor-
mation, it is unlikely that it could “force” the
molecule into an energetically unfavorable confor-
mation. In fact, conformational diversity in struc-
tures of the same protein has often been correlated
with functionally important motions. Thus, the
conformations captured in the SpnHyal-PEGMME
and SpnHyal-MALONATE structures can reason-
ably be supposed to be accessible to the enzyme and
hence of potential importance to its in vivo function.
In this regard, it should be noted that the pH values
at which the structures crystallized, pH 6.5 and 6.6
for the SpnHyal-PEGMME and SpnHyal-MALO-
NATE structures, respectively, are neither far from
the enzyme’s pH optimum of wpH 6.0–6.5, nor
very different from the pH 6.0 at which the enzyme
has previously been crystallized. The pneumococ-
cal Hyal is a very resilient enzyme and remains
active under variety of conditions including reason-
able amounts of ammonium sulfate (original
crystallization medium for this enzyme) or sodium
malonate salts, or PEG, including PEGMME (not
shown). As expected, however, at high concen-
trations of these crystallizing molecules the enzyme
activity is compromised. Regardless, the Hyal
molecules within crystalline lattice or once such
crystals are re-dissolved under standard assay
conditions9,10 they contain molecules capable of
full activity.13,17 Importantly, it is commonly thecase that the molecular dynamics simulations can
reproduce modes of structural variability observed
in sets of crystal structures and, indeed, we show
that to be the case for Hyal. Finally, the most
radically different conformation of SpnHyal
described here, SpnHyal-PEGMME, bears a clear
resemblance to a previous structure of SagHyal
making less likely the idea that it is an artifact of no
physiological relevance.
With the reliability of the new structures estab-
lished, their implications for our understanding of
Hyal flexibility and function will be discussed.
Based on computer simulations studies, a cleft
opening/closing motion (ii) has been predicted to
be essential for catalysis. The new SpnHyal-
PEGMME structure now provides the first experi-
mental evidence that directly points to the ability of
Hyal to achieve this earlier predicted open confor-
mation. Such an open conformation was previously
observed for SagHyal but the different species
origin of that protein left a doubt as to the
universality of the flexibility leading to the confor-
mation. The new structure reveals that this cleft-
widening motion is an intrinsic mechanistic prop-
erty of the enzyme, independent of the protein
source.
The structural differences between all Hyals may
be correlated to their modes of action, as revealed
by kinetic analysis with a variety of sub-
strates.14,24,25 As mentioned, biochemical data
demonstrate that Hyal cleavage of HA, its primary
substrate, proceeds via an initial endolytic cleavage
until the average HA chain decreases to approxi-
mately 300 kDa, at this stage another mode of action
based on processive, exolytic HA degradation of
one disaccharide at a time initiates. As HA chains
reach w100 disaccharides in length the rapid
exolytic and processive activity producing a solely
unsaturated disaccharide unit as the end degra-
dation product is the primary mode of
action.13,19,20,26 Such behavior is directly related to
HA aggregation when it is a large polymer, but such
aggregation decreases as the HA size diminishes
and below 40 kDa (100 disaccharides)27,28 HA
is thought to be not aggregated, resulting
in processive action of Hyal. Bacterial Hyals
degrade chondroitin substrates by a purely
endolytic process.
With the benefit of the new crystal structures
present here, and the wholly consistent multi-
nanosecond MD simulations reported, we feel
able to propose a consistent underlying molecular
mechanism of processive degradation of sub-
strate(s) by bacterial Hyals. The process would
consist of the following steps. Once the access to the
cleft is open (motion (iii)) and the cleft is widely
open (motion (ii)) the substrate is free to bind in the
cleft. Upon binding, the entrance closes (motion
(iii)) and the cleft width diminishes together with
catalytic residues moving into their functional
positions (motion (ii)). Once they perform catalysis,
the residues responsible for product release move in
to repel this product (motion (ii)). For further
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disaccharide at a time, the gate remains closed
(motion (iii)) preventing the substrate escape from
the cleft and the cleft widens (motion (ii)). The
substrate-bound enzyme then undergoes the twist-
ing motion (i), by which the substrate is translo-
cated in the direction of its reducing end byw10 A˚,
also the length of a disaccharide. This would be
followed by motion (ii), cleft closure and catalysis
then cleft opening and product release, and
repetition of the cycle until the substrate is fully
degraded in the processive manner. In the endolytic
degradation mode, both cleaved products would be
released from the cleft after the catalysis, a process
facilitated by gate opening (motion (iii)) and
widening of the cleft (motion (ii)). The type of
degradation is substrate specific and depends on
the length and aggregation of the substrate.18
Further experiments complemented by additional
simulations will be required to study the individual
steps in detail to verify the proposed mechanism.Conclusions
We have studied the structural basis of the
molecular mechanism underlying the cleavage of
substrates by bacterial Hyals by X-ray crystallo-
graphy, as well as by molecular dynamics simu-
lations. It is not common for enzymes to crystallize
under different conditions yielding different struc-
tures of the same enzyme. In the case of Hyals from
two streptococcal species, S. pneumoniae and
S. agalactiae, crystals in a number of structural
conformations were obtained. These conformations
were found to closely agree with the dynamic
behavior of the enzyme as studied by molecular
dynamics simulations and were convincingly
associated with the enzyme’s mechanism of pro-
cessive hyaluronan degradation at the molecular
level. Obtaining the new structures allowed for the
validation of the computational models of enzyme
action.
In addition, a basic property of the nature of the
processive mechanism of degradation was revealed
by diverse structural approaches. The flexibility of
Hyal appears to directly facilitate processivity of
this enzyme by threading the linear polymeric
substrate(s) through the enzymatic/catalytic cleft.
The significant insights into detailed mechanisms
on a microscopic level is not common, and for Hyals
they yielded a deeper understanding of this
process. There are numbers of aspects of this
enzyme’s functional behavior which are still not
understood, such as what is the significance of the
generation of disaccharide products, why nature
evolved to produce an unsaturated product only by
the action of bacterial and not animal Hyals, why
the disaccharides are presumably used as a source
of carbon and energy by bacteria, and what is the
mechanism of this product presumed transport
into bacterial cytoplasm? Further studies shouldfacilitate elucidation of these and other properties of
Hyals and their functionality.Materials and Methods
Crystallization, and diffraction data collection
The wild-type S. pneumoniae Hyal, in its fully functional
truncated form composed of the catalytic and C-terminal
domains only, was produced as reported.9,10 The protein
was concentrated to 5 mg/ml in 10 mM Tris–HCl buffer
(pH 7.4), 150 mM NaCl, 2 mM EDTA. For crystallization
the hanging drop vapor diffusion method was
employed29 and equal volumes (1 ml each) of the enzyme
and reservoir solution were utilized as reported.10 Two
new crystal forms were obtained. These crystals grew
within several months and were of different morphology
than of those of the wild-type enzyme reported.10 The first
set of crystals was obtained employing 30% (w/v)
polyethylene glycol monomethyl ether (PEGMME) 2000,
0.1 M Mes buffer (pH 6.5), and 0.2 M ammonium sulfate.
The second set of crystals was obtained utilizing 70%
(w/v) saturated malonic acid (pH 7.6) and 0.1 M sodium
cacodylate buffer (pH 6.6).
The crystals were cryo-protected and frozen using
standard methodology. The diffraction data were col-
lected using a synchrotron source, beamline 5.0.1 of the
Berkeley Center for Structural Biology, Advanced Light
Source, Lawrence Berkeley National Laboratory. An
ADSC Quantum 4u CCD detector was used and the
data were collected in oscillation mode.30 The new
crystals were not isomorphous to those of the original
crystals of this wild-type enzyme.10 The PEGMME
crystals yielded X-ray diffraction data at 2.8 A˚, and
indexed to the P21 space group with unit cell dimensions
aZ86.4 A˚, bZ83.3 A˚, cZ98.7 A˚, and gZ98.88. The malo-
nate crystals yielded a 3.3 A˚ diffraction data set, space
group C2, and unit cell dimensions of aZ117.7 A˚, bZ
101.1 A˚, cZ85.2 A˚, and gZ125.18. The reasons for the
relatively poor diffraction by the new crystal form are
unclear. Heterogeneity in the protein sample seems
unlikely, since Hyal readily and reproducibly crystallizes
in the original crystal form. Neither new crystal form is
characterized by a high solvent content, 43% for the
malonate-derived crystals and 50% for the PEGMME
crystals. The crystal took a very long time to grow, and
conceivably the structural flexibility of the enzyme is
reflected in the crystal quality and the resulting X-ray
diffraction data.
Structure solution and refinement
The structures were solved by molecular replacement
methods employing the MOLREP program31 and utiliz-
ing the 1.56 A˚ crystal structure of the wild-type S. pneu-
moniae Hyal structure (SpnHyal) as a search model. This
structure was then divided into smaller portions based on
the structural and dynamic domains previously identi-
fied.13,17 This approach was necessary to achieve a
successful solution of the SpnHyal-PEGMME structure.
Solutions were further refined using rigid body refine-
ment in CNS.32 Refinement was principally done with
CNS32 but REFMAC5,33 in combination with ARP/
WARP,34 proved to be useful at the first stage of positional
refinement of SpnHyal-MALONATE. Computational
refinement was alternated with manual rebuilding with
O.35 All data were used throughout with no intensity or
1176 Flexibility of Hyaluronan Lyasesigma-based cut-offs applied. SigmaA-weighted map
coefficients36 were used throughout. Maximum
likelihood functions were used throughout. An Rfree
value,37 calculated from 5% of reflections set aside at
the outset, was used to monitor the progress of
refinement. The asymmetric unit of the SpnHyal-
PEGMME crystal form contains two Hyal chains. During
initial refinement, these were constrained to identical
conformations with CNS. Later, the constraints were
replaced by restraints and, where density suggested
conformational differences between the chains, specific
regions were exempted entirely from the restraints.
During the final stages of refinement exempted residues
were 385–388, 420–433, 435, 444, 492–493, 518, 524 and
527–540. At a late stage, water molecules were placed into
3s positive peaks in jFoKFcj maps when density was also
evident in j2FoKFcj maps and suitable hydrogen bonding
partners were available. Sulfate and malonate ions
derived from the crystallization solutions were modeled
into suitably shaped regions of electron density. Tem-
perature factors were refined first on a per-residue basis,
and then per-atom for a limited number of iterations
guided by the behavior of the Rfree value. Final statistics
for the two structures are presented in Table 2. The water
molecules in the SpnHyal-PEGMME structures refined to
atypically low values. The reasons for this are unclear but
may include (1) the fact that they were picked conserva-
tively and so the final group represents the best-ordered
subset and (2) some of the water molecules are in fact
heavier cations or anions, hard to distinguish at the
available resolution. Programs of the CCP4 package38
were used for all data and structure manipulations and
structural superpositions were performed with
LSQMAN.39
Structural alignments and superpositions for compari-
son purposes were performed based on the alignment of
the catalytic a-domain only. Structural placement and
positioning of the HA substrate within the cleft was
performed based on the superposition of individual
structures with that of the published S. pneumoniae
holoHyal–HA hexasaccharide complex structure.8 The
comparison with the S. agalactiae Hyal–HA complex was
based on the alignment (based on Ca atoms of the
a-domain only) with the published structure of its
complex with HA hexasaccharide.17 All structural
Figures were produced with PyMol,† Ribbons,40 or
Grasp.41Molecular dynamics simulations
MD simulations of 50 ns each were carried out on
SpnHyal-apo and SpnHyal-holo (see Table 1). The simu-
lations were carried out using the GROMACS simulation
suite,42 employing the optimized potentials for liquid
simulations, all atom (OPLS-AA) force field.43 Hyalur-
onan parameters were derived by modifying the mole-
cule-specific dihedral parameters in the OPLS-AA force
field for the carbohydrate substrate.44 The enzyme was
solvated in a periodic box of TIP4P water molecules,
resulting in a simulation size of 77,278 and 83,542 atoms
for the SpnHyal-apo and SpnHyal-holo simulations,
respectively. LINCS45 was used to constrain covalent
bonds, allowing a time step of 2 fs. The temperature was
kept constant at 300 K by separately coupling (time step
tZ0.1 ps) protein and solvent to an external temperature
bath.46 Likewise, the pressure was kept at 1 bar (tZ1 ps)† http://pymol.sourceforge.netby using a Berendsen barostat.46 Electrostatic interactions
were calculated using the smooth particle mesh Ewald
(PME) method.47Other methods
The Dyndom22 method was used to analyze domain
motions. The enzyme concentration was determined by
UV absorption at 280 nm using the molar extinction
coefficient calculated based on the native or mutant
S. pneumoniae Hyal amino acid residue sequence data.9,10
The calculated molar extinction coefficient was 127,090 for
the wild-type truncated enzyme used.
Principal component analysis (PCA) is a tool for
filtering large-scale collective fluctuations from MD
trajectories or a set of experimental structures. The
method is based on the diagonalization of the covariance
matrix of atomic fluctuations, which yields a set of
eigenvalues and eigenvectors. The eigenvectors indicate
directions in a 3n-dimensional space (with n being the
number of atoms of the protein) and describe concerted
fluctuations of the atoms. The eigenvalues reflect the
magnitude of the fluctuation along of the respective
eigenvectors. To compare the collective motions of two
simulations of SpnHyal-apo and SpnHyal-holo, the PCA
was first performed on crystallographic data available.
The available dataset includes X-ray structures of Hyal
from both S. pneumoniae and S. agalactiae in both apo and
holo forms and comprises the structures in Table 1 along
with structures having PDB codes 1c82, 1i8q, 1lxk and
1lxm (other substrate complexes) and 1f9g (a vitamin C
complex). The two simulations were projected onto this
set of eigenvectors for comparison.Protein Data Bank accession codes
The coordinates and structural factors of both struc-
tures, SpnHyal-PEGMME and SpnHyal-MALONATE,
have been deposited in the Protein Data Bank with
accession numbers 2brw, 2brv, and r2brwsf, r2brvsf,
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